Immatics N.V. (IMTXW) Financials
IMTXW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 463.1 million | 200.8 million |
2023-06-30 | 446.0 million | 208.7 million |
2023-03-31 | 412.6 million | 194.5 million |
2022-12-31 | 437.7 million | 208.9 million |
IMTXW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -39.2 million | 5.0 million |
2023-06-30 | -19.0 million | 6.0 million |
2023-03-31 | -30.6 million | 6.7 million |
2022-12-31 | -36.5 million | 6.3 million |
IMTXW Net Income
No data available :(
IMTXW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 387.5 million | - | 17.4 million |
2023-06-30 | 378.0 million | - | 18.3 million |
2023-03-31 | 359.5 million | - | 16.3 million |
2022-12-31 | 388.7 million | - | 15.6 million |
IMTXW Shares Outstanding
IMTXW Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 6.9 million | 32.3 million | 9.4 million | - |
2023-06-30 | 11.8 million | 29.7 million | 7.4 million | - |
2023-03-31 | 4.7 million | 30.1 million | 10.4 million | - |
2022-12-31 | 2.8 million | 29.9 million | 10.5 million | - |
IMTXW Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 6.3 million | - |
2023-06-30 | 24.3 million | 29.7 million |
2023-03-31 | 10.7 million | 30.1 million |
2022-12-31 | 40.4 million | 29.9 million |
IMTXW
Price: $2.51
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 100577
Market Capitalization: 673.0 million